TORONTO - Health Canada has authorized updated COVID-19 vaccines by Pfizer and BioNTech and by Moderna for use this respiratory virus season.

The biotech company said Friday the latest version of its Covid-19 mRNA vaccine, Spikevax, has been authorized by Health Canada. And for the first time, all pre-filled syringe doses of the vaccine ...

Earlier this week, I posted a question on social media. It went something like this, “Without sarcasm, political insults or ...

One of the highest yields you can get right now is from Pfizer ( PFE 0.90%). The healthcare giant offers a yield of 6.8%, ...

Pfizer's Canadian unit and BioNTech said they have received approval in Canada for their updated Comirnaty Covid-19 vaccine. The companies said Monday the updated vaccine targets the Omicron LP.8.1 ...

Pfizer Canada (PFE) and BioNTech (BNTX) announced that Health Canada has authorized the LP.8.1 variant adapted COMIRNATY COVID-19 vaccine for ...

An updated guideline on pharmacotherapy of obesity management in adults includes six new and seven revised recommendations, ...

Both Pfizer Canada and Moderna Canada confirmed to The Canadian Press on Thursday that the U.S. backing away from mRNA vaccines should not affect availability of their updated COVID-19 vaccines in ...

Pfizer's beleaguered obesity strategy has hit another setback as the pharma jettisoned its third and final GLP-1 agonist, citing poor data and tough competition. Pfizer's last remaining GLP-1 ...

Pfizer exceeds analyst expectations with $0.78 EPS and $14.7B revenue in Q2 2025, beating estimates by significant margins despite recent stock struggles.

Pfizer CEO Albert Bourla is expected at a pro-Trump fundraiser on Friday, sources told CBS News, one day after the president sent a letter pushing drug companies to slash prices.